Prescribing in hypertension

This retrospective cohort analysis published in the Journal of Pharmacy Technology in 2022 aimed to describe prescribing patterns of antihypertensive medications in patients with incident stage 2...

When should pharmacological cognitive enhancers be used?

Audit and re-audit of medication use in patients with impaired kidney function

To identify medications that were most likely to be prescribed at inappropriate doses in patients with CKD 3-5, and to implement methods to improve patient care in this area by sharing results with...

A warfarin-antibiotic drug-drug interaction: a podiatric surgical case report

Patient A (Table 1) presented in 2016 with pain in both feet across the lesser metatarsal-phalangeal joints (MTPJs). On clinical examination, she had pain in both third/fourth intermetatarsal (IM)...

Costs and consequences of services provided by non-medical prescribers: a scoping review protocol

This scoping review protocol was registered with the Open Science Framework Registry on 31 July 2021 (registered DOI: 10.17605/OSF.IO/PSR3N), accessible from https://osf.io/psr3n..

Alzheimer's disease and ethics

Sexual and reproductive health prescribing

This original research study, published in the Journal of Advanced Nursing in January 2022 aimed to compare the implications of using nurse prescribing and the use of patient group directions (PGDs)...

Gabapentinoids in renal impairment

Review the doses and identify patients that require a consultation to have their doses adjusted..

The pharmacology of allergic rhinitis treatments

Many PwAR experience mild symptoms (Dykewicz et al, 2020) and dismiss AR as little more than a nuisance (Bjermer et al, 2019).

Maintenance niraparib therapy for patients with relapsed platinum sensitive ovarian cancer: experience at a south coast network

PARP inhibitors have recently entered the treatment pathway for gynaecological cancers; primarily ovarian, fallopian tube and peritoneal cancers (The National Institute of Health and Care Excellence...

New medication tackles obesity

Quetiapine

Day 1: #quetiapine is a derivative of the 2nd generation atypical antipsychotic clozapine, with a superior side-effect profile. Developed in the 80s/90s, #quetiapine was approved for schizophrenia in...